Balapadang, R. N., and H. Sudarjat. “Potential of Beta-Hydroxybutyrate (BHB) in the Management of Type 2 Diabetes and Risk of Ketoacidosis in Diabetic Patients”. Journal of Pharmaceutical and Sciences, vol. 7, no. 4, Oct. 2024, pp. 562-70, doi:10.36490/journal-jps.com.v7i4.520.